Log In
BCIQ
Print this Print this
 

Anlotinib

  Manage Alerts
Collapse Summary General Information
Company Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
DescriptionMulti-target receptor tyrosine kinase inhibitor
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1) ; Vascular endothelial growth factor (VEGF) receptor 3 (FLT4) (VEGFR-3)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today